WallStreetZenWallStreetZen

NASDAQ: MBRX
Moleculin Biotech Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Moleculin Biotech earnings were -$32.2M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest MBRX earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$14.6M, down 194.6% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, MBRX reported annual earnings of -$33.7M, with 29.2% growth. The next MBRX earnings date is Aug 11, 2026.

MBRX earnings history

Current Revenue
$0.0
Current Earnings
-$32.2M
Current Profit Margin
0%

MBRX Return on Equity

Current Company
N/A
Current Industry
-141.9%
Current Market
13.5%

MBRX Return on Assets

Current Company
-147.3%
Current Industry
-13.7%
MBRX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when MBRX announces earnings.

MBRX Return on Capital Employed

Current Company
-196.95%
Current Industry
-9.6%
MBRX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

MBRX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
MBRX-$30.27M-$32.20MN/A-$2.16
AZTR-$11.34M-$11.81MN/A-$1.31
DCOY-$13.02M-$13.03MN/A-$63.98
OGEN-$9.40M-$9.83MN/A-$4.97
CLDI-$17.16M-$25.01MN/A-$67.10
View Top Biotech Stocks

MBRX earnings dates

Next earnings date
Aug 11, 2026

Moleculin Biotech Earnings Reports & History FAQ

What were Moleculin Biotech's earnings last quarter?

Moleculin Biotech (NASDAQ: MBRX) reported Q1 2026 earnings per share (EPS) of -$3.54, up 77.59% year over year. Total MBRX earnings for the quarter were -$14.61 million. In the same quarter last year, Moleculin Biotech's earnings per share (EPS) was -$15.80.

If you're new to stock investing, here's how to buy Moleculin Biotech stock.

When does Moleculin Biotech report earnings?

The next MBRX earnings call is Aug 11, 2026. Add MBRX to your watchlist to be reminded of Moleculin Biotech's next earnings date.

Is Moleculin Biotech profitable or losing money?

As of the last Moleculin Biotech earnings report, Moleculin Biotech is currently losing money. Moleculin Biotech's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$30.33 million, a 27.28% increase year over year.

What was MBRX's earnings growth in the past year?

As of Moleculin Biotech's earnings date in Q3 2026, Moleculin Biotech's earnings has grown year over year. MBRX earnings in the past year totalled -$32.20 million.

What are Moleculin Biotech's earnings expectations?

The current EPS estimate for Moleculin Biotech's earnings report in Aug 11, 2026 is -$1.53.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.